Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BiomX Inc. terminated Open Market Sale Agreement SM with Jefferies LLC valued at aggregate offering price of up to $50,000,000 (as later reduced to $19,950,000) (effective 2023-12-07).
- Action
- termination
- Agreement
- atm program
- Counterparty
- Jefferies LLC
- Value
- aggregate offering price of up to $50,000,000 (as later reduced to $19,950,000)
- Effective
- 2023-12-07
Exact text from the filing
On December 7, 2023, the Company and Jefferies LLC, or Jefferies, entered into a Termination and Waiver Agreement providing for the termination of the Open Market Sale Agreement SM , dated December 4, 2020, or the Sales Agreement, between the Company and Jefferies.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
BiomX Inc. entered into At the Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $7.5 million (effective 2023-12-07).
- Action
- entry
- Agreement
- atm program
- Counterparty
- H.C. Wainwright & Co., LLC
- Value
- up to $7.5 million
- Effective
- 2023-12-07
Exact text from the filing
On December 7, 2023, BiomX Inc., or the Company, entered into an At the Market Offering Agreement, or the Offering Agreement, with H.C. Wainwright & Co., LLC, or Wainwright, as manager, pursuant to which the Company may issue and sell shares of its common stock, $0.0001 par value per share, or Common Stock, having an aggregate offering price of up to $7.5 million from time to time through Wainwright.
View on SEC.gov